Search Results - "Peredo, I"

Refine Results
  1. 1

    Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact by Fornara, O, Bartek Jr, J, Rahbar, A, Odeberg, J, Khan, Z, Peredo, I, Hamerlik, P, Bartek, J, Stragliotto, G, Landázuri, N, Söderberg-Nauclér, C

    Published in Cell death and differentiation (01-02-2016)
    “…Glioblastoma (GBM) is associated with poor prognosis despite aggressive surgical resection, chemotherapy, and radiation therapy. Unfortunately, this standard…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Clinical Assessment of 2 Licensed AbobotulinumtoxinA Injection Volumes for the Treatment of Glabellar Lines by Kaufman, Joely, Cohen, Joel L, Peredo, Marina I, Jonas, Brandie, Down, Rebecca, Nogueira, Alessandra

    Published in Dermatologic surgery (01-10-2019)
    “…BACKGROUNDTwo licensed reconstitution volumes may be used to achieve the recommended abobotulinumtoxinA (ABO) dose for glabellar line correction…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival by Rahbar, Afsar, Orrego, Abiel, Peredo, Inti, Dzabic, Mensur, Wolmer-Solberg, Nina, Strååt, Klas, Stragliotto, Giuseppe, Söderberg-Nauclér, Cecilia

    Published in Journal of clinical virology (01-05-2013)
    “…Abstract Background Patients with glioblastoma multiforme (GBM) generally live 12–15 months after diagnosis, despite maximal surgical resection, adjuvant…”
    Get full text
    Journal Article
  8. 8

    Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients by Rahbar, Afsar, Cederarv, Madeleine, Wolmer-Solberg, Nina, Tammik, Charlotte, Stragliotto, Giuseppe, Peredo, Inti, Fornara, Olesja, Xu, Xinling, Dzabic, Mensur, Taher, Chato, Skarman, Petra, Söderberg-Nauclér, Cecilia

    Published in Oncoimmunology (01-02-2016)
    “…Glioblastoma multiforme (GBM) is a highly malignant tumor with a poor outcome that is often positive for human cytomegalovirus (HCMV). GBM patients often have…”
    Get full text
    Journal Article
  9. 9

    Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma by Holmberg, Johan, He, Xiaobing, Peredo, Inti, Orrego, Abiel, Hesselager, Göran, Ericsson, Christer, Hovatta, Outi, Oba-Shinjo, Sueli Mieko, Marie, Suely Kazue Nagahashi, Nistér, Monica, Muhr, Jonas

    Published in PloS one (31-03-2011)
    “…The presence of stem cell characteristics in glioma cells raises the possibility that mechanisms promoting the maintenance and self-renewal of tissue specific…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma by Valentini, Davide, Rao, Martin, Meng, Qingda, von Landenberg, Anna, Bartek, Jr, Jiri, Sinclair, Georges, Paraschoudi, Georgia, Jäger, Elke, Harvey-Peredo, Inti, Dodoo, Ernest, Maeurer, Markus

    Published in Oncotarget (13-04-2018)
    “…Neoepitope-specific T-cell responses have been shown to induce durable clinical responses in patients with advanced cancers. We explored the recognition…”
    Get full text
    Journal Article
  12. 12

    Valganciclovir in Patients with Glioblastoma by Hellstrand, Kristoffer, Martner, Anna, Bergström, Tomas, Söderberg-Nauclér, Cecilia, Peredo, Inti, Stragliotto, Giuseppe

    Published in The New England journal of medicine (21-11-2013)
    “…To the Editor: Söderberg-Nauclér et al. (Sept. 5 issue) 1 report that cytomegalovirus (CMV) antigens are detected in more than 99% of human glioblastomas. In…”
    Get full text
    Journal Article
  13. 13

    NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma by Liu, Zhenjiang, Poiret, Thomas, Persson, Oscar, Meng, Qingda, Rane, Lalit, Bartek, Jiri, Karbach, Julia, Altmannsberger, Hans-Michael, Illies, Christopher, Luo, Xiaohua, Harvey-Peredo, Inti, Jäger, Elke, Dodoo, Ernest, Maeurer, Markus

    Published in CANCER IMMUNOLOGY IMMUNOTHERAPY (01-02-2018)
    “…The prognosis for patients with glioblastoma is grim. Ex vivo expanded tumor-associated antigen (TAA)-reactive T-cells from patients with glioma may represent…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma by Liu, Zhenjiang, Rao, Martin, Poiret, Thomas, Nava, Silvia, Meng, Qingda, von Landenberg, Anna, Bartek, Jr, Jiri, Xie, Shanshan, Sinclair, Georges, Peredo, Inti, Dodoo, Ernest, Maeurer, Markus

    Published in Oncotarget (06-10-2017)
    “…Glioblastoma multiforme (GBM) presents the most malignant form of glioma, with a 5-year survival rate below 3% despite standard therapy. Novel immune-based…”
    Get full text
    Journal Article
  16. 16

    Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery by Fornara, Olesja, Odeberg, Jenny, Wolmer Solberg, Nina, Tammik, Charlotte, Skarman, Petra, Peredo, Inti, Stragliotto, Giuseppe, Rahbar, Afsar, Söderberg-Nauclér, Cecilia

    Published in Oncoimmunology (01-01-2015)
    “…Patients with glioblastoma multiforme (GBM) are immunosuppressed and have a broad range of immunological defects in both innate and adaptive immune responses…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry by Mathiesen, Tiit, Peredo, Inti, Lönn, Stefan

    Published in Acta neurochirurgica (01-03-2011)
    “…Background Swedish health care legislation requires equal, high-quality health care for all inhabitants, while regional differences of medical availability and…”
    Get full text
    Journal Article
  19. 19

    Effects of valgancidovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study by Stragliotto, G, Rahbar, A, Solberg, N W, Lilja, A, Taher, C, Orrego, A, Bjurman, B, Tammik, C, Skarman, P, Peredo, I, Soederberg-Naucler, C

    Published in International journal of cancer (01-09-2013)
    “…Cytomegalovirus is highly prevalent in glioblastomas. In 2006, we initiated a randomized, double-blind, placebo-controlled, hypothesis-generating study to…”
    Get full text
    Journal Article
  20. 20